Hans‐Jürgen Seyfarth

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 516 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension

Marius M. Hoeper, Christine Pausch, Karen M. Olsson et al. · European Respiratory Journal · 2021 · 338 citations · Full text

Medicine, Cardiology, Pulmonology +14

Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial

Nicola Ehlken, Mona Lichtblau, Hans Klose et al. · European Heart Journal · 2015 · 243 citations · Full text

Medicine, Cardiology, Exercise Physiology +16

Safety and efficacy of exercise training in various forms of pulmonary hypertension

Ekkehard Grünig, Mona Lichtblau, Nicola Ehlken et al. · European Respiratory Journal · 2012 · 236 citations · Full text

Medicine, Cardiology, Rehabilitation Medicine +14

Assessment and Prognostic Relevance of Right Ventricular Contractile Reserve in Patients With Severe Pulmonary Hypertension

Ekkehard Grünig, Henning Tiede, Esi Otuwa Enyimayew et al. · Circulation · 2013 · 216 citations · Full text

Medicine, Cardiology, Clinical Cardiology +14